Exchange Ranking
Top Exchanges
24h Volume Ranking
Popularity Ranking
Exchange BTC Balance
Proof of Reserves
Decentralized Exchanges
Funding Rate
Funding Heatmap
Liquidation Data
Max Pain
Long/Short Ratio
Whale L/S Ratio
Binance/Okex/Huobi L/S
Bitfinex Margin L/S
ETF Tracker
Solana ETF
XRP ETF
Hong Kong ETF
Bitcoin Treasuries
Crypto Reversal
Ethereum Reserves
HyperLiquid Wallet Analysis
Hyperliquid Whale Watch
Large Transactions
On-chain Movement
Bitcoin ROI
Stablecoin Market Cap
Options Analysis
News
Articles
Economic Calendar
Features
Wallet
Contract Calculator
Security
Collections
Watchlist
Following
HYPE Article Overview
Hyperliquid Strategies expanded the size of its equity financing vehicle with Chardan Capital Markets from US$1 billion to US$2.5 billion on September 1. The tool allows companies to sell newly issued shares over time, but there is no guarantee that funds will be available.
As of August 19, the company held approximately 29.3 million HYPE tokens, with a total purchase value of more than US$773 million. The new agreement sets a trading cap: once the cumulative financing through the instrument reaches US$1 billion, no more shares can be sold if the share price falls below US$12.02. On September 1, the company's stock closed at $11.36, down about 7.3% on the day.
How equity financing instruments work
Under the agreement, Hyperliquid Strategies can direct Chardan to purchase newly issued shares at different points in time, and Chardan will then resell those shares on the open market. The company determines the timing and quantity of sales independently, depending on market conditions, stock prices and management's plan for the use of funds. The proceeds will be used for general corporate purposes and may include increasing the holding of more HYPE tokens. This clause gives management flexibility rather than setting fixed token purchase targets or deadlines.
Selling shares will increase total share capital, which may result in dilution of existing investors 'shareholdings. Prior to this expansion, the company had raised a total of US$647 million through this instrument, which helped it expand HYPE's positions to its current size.
HYPE's Position and Recent Stock Price Trends
Since completing the business merger in December 2025, Hyperliquid Strategies has spent US$773.4 million to purchase approximately 16.5 million HYPE tokens, with an average purchase price of US$46.77 each. As of August 19, the company held approximately 29.3 million HYPEs. As of the end of June, the company reported a cash balance of $149.9 million and no debt.
New trading cap rules
The new agreement includes a cap based on Nasdaq rules. Once cumulative sales through the tool reach US$1 billion, companies are typically not allowed to sell more than 42,641,847 shares at a price less than US$12.02 per share without shareholder approval. This number of shares accounted for approximately 19.99% of the issued shares before the amendment. At $12.02 per share, this stake would bring in approximately $512.5 million before expenses.
Market Reactions and Updates
On September 1, Hyperliquid Strategies 'share price closed at US$11.36, down about 7.3% on the day. The intraday trading range was US$11.03 to US$12.31, with volume close to 24.3 million shares. The closing price has fallen below the $12.02 threshold involved in the new cap rule. But the cap will only take effect after cumulative sales through the tool exceed US$1 billion.
The regulatory documents did not disclose whether the company had used the new financing line, nor did they report new HYPE purchases related to this revision. Last month, market attention to Hyperliquid grew after regulators said they were working to incorporate the platform into the U.S. regulatory framework. After the comments were made, the price of HYPE token rose more than 20%, and Hyperliquid Strategies shares rose 30.4% over the same period. The company said it operates independently and is not associated with the Hyperliquid agreement, despite having the same name and holding its tokens.
